Samsung Bioepis, a biosimilar drug developer under the Samsung Group, announced on Tuesday that it has received approval to sell its biosimilar treatment for autoimmune diseases in Japan, Azernews reports, citing Korean media.
The Budapest Public Transport Center (BKK) has signed a contract to launch the third generation of the MOL Bubi urban bike rental system, Azernews reports.
The South Caucasus News - SouthCaucasusNews.com